| Gadodiamide | Approved Investigational | RHOQ | 23433 |
upregulated | gadodiamide results in increased expression of RHOQ mRNA | 2p21 | |
| Gadodiamide | Approved Investigational | RIT1 | 6016 |
upregulated | gadodiamide results in increased expression of RIT1 mRNA | 1q22 | |
| Gadodiamide | Approved Investigational | RNF125 | 54941 |
upregulated | gadodiamide results in increased expression of RNF125 mRNA | 18q12.1 | |
| Gadodiamide | Approved Investigational | RSAD2 | 91543 |
upregulated | gadodiamide results in increased expression of RSAD2 mRNA | 2p25.2 | |
| Gadodiamide | Approved Investigational | SLC39A10 | 57181 |
upregulated | gadodiamide results in increased expression of SLC39A10 mRNA | 2q32.3 | |
| Gadodiamide | Approved Investigational | SPN | 6693 |
upregulated | gadodiamide results in increased expression of SPN mRNA | 16p11.2 | |
| Gadodiamide | Approved Investigational | TGFB1 | 7040 |
upregulated | gadodiamide results in increased expression of TGFB1 mRNA | 19q13.1 | |
| Gadodiamide | Approved Investigational | TIMP1 | 7076 |
upregulated | gadodiamide results in increased expression of TIMP1 mRNA | Xp11.3 | |
| Gadodiamide | Approved Investigational | UBD | 10537 |
upregulated | gadodiamide results in increased expression of UBD mRNA | 6p22.1 | |
| Gadodiamide | Approved Investigational | VEGFA | 7422 |
upregulated | gadodiamide results in increased expression of VEGFA mRNA | 6p21.1 | |
| Gadodiamide | Approved Investigational | WDR5 | 11091 |
upregulated | gadodiamide results in increased expression of WDR5 mRNA | 9q34.2 | |
| Gadodiamide | Approved Investigational | XIAP | 331 |
upregulated | gadodiamide results in increased expression of XIAP mRNA | Xq25 | |
| Gadodiamide | Approved Investigational | ZNF595 | 152687 |
upregulated | gadodiamide results in increased expression of ZNF595 mRNA | 4p16.3 | |
| Gadodiamide | Approved Investigational | ZNF652 | 22834 |
upregulated | gadodiamide results in increased expression of ZNF652 mRNA | 17q21.32 | |
| Gadolinium | Approved Investigational Withdrawn | IFNG | 3458 |
upregulated | gadolinium chloride results in increased expression of IFNG mRNA | 12q15 | |
| Gadolinium | Approved Investigational Withdrawn | IL13 | 3596 |
upregulated | gadolinium chloride results in increased expression of IL13 mRNA | 5q31.1 | |
| Gadolinium | Approved Investigational Withdrawn | IL6 | 3569 |
upregulated | gadolinium chloride results in increased expression of IL6 mRNA | 7p15.3 | |
| Gadolinium | Approved Investigational Withdrawn | TNFRSF11B | 4982 |
upregulated | gadolinium chloride results in increased expression of TNFRSF11B mRNA | 8q24.12 | |
| Gadolinium | Approved Investigational Withdrawn | TNFSF11 | 8600 |
downregulated | gadolinium chloride results in decreased expression of TNFSF11 mRNA | 13q14 | |
| Gadolinium | Approved Investigational Withdrawn | VEGFA | 7422 |
upregulated | gadolinium chloride results in increased expression of VEGFA mRNA | 6p21.1 | |
| Galactose | Approved Investigational Withdrawn | AOX1 | 316 |
upregulated | Galactose results in increased expression of AOX1 mRNA | 2q33.1 | |
| Galactose | Approved Investigational Withdrawn | ATOX1 | 475 |
downregulated | Galactose results in decreased expression of ATOX1 mRNA | 5q33.1 | |
| Galactose | Approved Investigational Withdrawn | GSS | 2937 |
downregulated | Galactose results in decreased expression of GSS mRNA | 20q11.22 | |
| Galactose | Approved Investigational Withdrawn | TXNRD1 | 7296 |
downregulated | Galactose results in decreased expression of TXNRD1 mRNA | 12q23.3 | |
| Gallium nitrate | Approved Investigational | ABCB7 | 22 |
downregulated | gallium nitrate results in decreased expression of ABCB7 mRNA | Xq13.3 | |